Clinical Trial

Corticosteroids for Doxorubicin Liposome-Induced Hand-Foot-Skin Reactions

Study acronym: CHORD
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2026 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Investigating the Association Between Corticosteroid Use and Improvement in Doxorubicin Liposome-Induced Cutaneous Toxicity: Exploring the Feasibility and Mechanisms of Corticosteroids in Mitigating Liposomal Doxorubicin-Related Dermatologic Adverse Effects.
Trial Details
NCT Number NCT07362914
Lead Sponsor Fudan University
Conditions Breast Cancer
Enrollment 182 participants
Start Date 2025-03-07
Primary Completion 2026-07-30 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-23